Lithium 3-[[[(3S)-1-azabicyclo[2.2.2]octan-3-yl]amino]methyl]-1-ethylindazole-4-carboxylate
C18H23LiN4O2 — CID 66772130
Data last refreshed: (MolForge compound catalog, from PubChem)
About Lithium 3-[[[(3S)-1-azabicyclo[2.2.2]octan-3-yl]amino]methyl]-1-ethylindazole-4-carboxylate
Lithium 3-[[[(3S)-1-azabicyclo[2.2.2]octan-3-yl]amino]methyl]-1-ethylindazole-4-carboxylate (PubChem CID 66772130) has the molecular formula C18H23LiN4O2 and a molecular weight of 334.35 g/mol. Its IUPAC name is lithium 3-[[[(3S)-1-azabicyclo[2.2.2]octan-3-yl]amino]methyl]-1-ethylindazole-4-carboxylate.
Molecular Properties
| Compound Name | Lithium 3-[[[(3S)-1-azabicyclo[2.2.2]octan-3-yl]amino]methyl]-1-ethylindazole-4-carboxylate |
|---|---|
| PubChem CID | 66772130 |
| Molecular Formula | C18H23LiN4O2 |
| Molecular Weight | 334.35 g/mol |
| Exact Mass | 334.20 |
| IUPAC Name | lithium 3-[[[(3S)-1-azabicyclo[2.2.2]octan-3-yl]amino]methyl]-1-ethylindazole-4-carboxylate |
| SMILES | CCn1nc(CN[C@@H]2CN3CCC2CC3)c2c(C(=O)[O-])cccc21.[Li+] |
| InChI | InChI=1S/C18H24N4O2.Li/c1-2-22-16-5-3-4-13(18(23)24)17(16)14(20-22)10-19-15-11-21-8-6-12(15)7-9-21;/h3-5,12,15,19H,2,6-11H2,1H3,(H,23,24);/q;+1/p-1/t15-;/m1./s1 |
| InChIKey | ZBLNRQFYNHYVDH-XFULWGLBSA-M |
| XLogP | -2.39 |
| TPSA | 73.22 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 334.35 |
| LogP ≤ 5 | -2.39 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 66772130 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.